Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-385-7 | CAS number: 58-55-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well documented publication/study report.
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 988
- Reference Type:
- secondary source
- Title:
- Reproductive effects of theophylline in mice and rats.
- Author:
- Morrissey, R.E.
- Year:
- 1 988
- Bibliographic source:
- Fund. Appl. Toxicol. 10, 525-536; cited in: OECD SIDS for CAS-No. 58-55-9, 2003
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 998
- Reference Type:
- publication
- Title:
- Theophylline-induced mesenteric periarteritis in F344/N rats.
- Author:
- Nyska, A.
- Year:
- 1 998
- Bibliographic source:
- Arch. Toxicol. 72, 731-737
- Reference Type:
- secondary source
- Title:
- Subchronic Toxicity of Orally Administered (Gavage and Dosed-Feed) Theophylline in Fischer 344 Rats and B6C3F Mice.
- Author:
- Collins, J.J.
- Year:
- 1 988
- Bibliographic source:
- Fund. Appl. Toxicol. 11, 472-484; cited in: OECD SIDS for CAS-No. 58-55-9, 2003
- Reference Type:
- secondary source
- Title:
- Theophylline-induced mesenteric periarteritis in F344/N rats.
- Author:
- Nyska, A.
- Year:
- 1 998
- Bibliographic source:
- Arch. Toxicol. 72, 731-737; cited in: OECD SIDS for CAS-No. 58-55-9, 2003
- Reference Type:
- secondary source
- Title:
- Unnamed
- Year:
- 1 998
Materials and methods
- Principles of method if other than guideline:
- Standard method of the National Toxicology Program (NTP) without recovery period.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Theophylline
- EC Number:
- 200-385-7
- EC Name:
- Theophylline
- Cas Number:
- 58-55-9
- Molecular formula:
- C7H8N4O2
- IUPAC Name:
- 1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
- Details on test material:
- - Name of test material (as cited in study report): theophylline
- Analytical purity: according to Collins et al., 1988, the purity was >99%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: approximately 4 weeks;
- Housing: 5 per cage
- Diet (e.g. ad libitum): NIH-07 open formula rodent feed; pellets for the gavage studies;
- Water (ad libitum):tap water;
- Acclimation period: 2 weeks.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.1 - 25 °C;
- Humidity (%): 35 - 70 %;
- Air changes (per hr): 10;
- Photoperiod (hrs dark / hrs light): 12h/12h.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
- Dose formulations were prepared weekly during the 13-week studies by mixing theophylline with corn oil to give the required concentrations . Homogeneity and stability studies of the dose formulations were performed using HPLC and ultraviolet/visible spectroscopy. Homogeneity was confirmed for the gavage formulations.
DOSING SOLUTION:
- Gavage volume: 5 mL/kg b.w. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Dosage analyses (ultraviolet spectrophotometric) both prior to and after dosing confirmed that the dosage formulation in corn oil (dosage formulations in corn oil were suspensions) were homogenous and were within ±10% of the target concentrations.
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- 5 d/w (daily, excluding weekends and holidays, for a total of 65 - 69 dosing days).
Doses / concentrations
- Remarks:
- Doses / Concentrations:
37.5, 75, 150 mg/kg bw/d
Basis:
actual ingested
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Post-exposure recovery period in satellite groups: none
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes;
- Time schedule: twice a day;
DETAILED CLINICAL OBSERVATIONS: Yes;
- Time schedule: once a week;
BODY WEIGHT: Yes;
- Time schedule for examinations: once a week;
HAEMATOLOGY: Yes;
- Time schedule for collection of blood: at terminal kill from the retro-orbital sinus of the rats;
- Anaesthetic used for blood collection: Yes (identity): CO2;
- Parameters examined: The blood was analyzed using an automated hematology analyzer (Ortho ELG-8) for erythrocyte, platelet, and leukocyte counts, hematocrit, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and mean corpuscular volume. Hematocrit values were based upon erythrocyte counts, and hemoglobin was measured by colorimetric determination of cyanmethemoglobin. Leukocyte differential, reticulocyte counts, and erythrocyte, platelet, and leukocyte morphologies were determined by light microscopy on blood smears stained with a combination of methylene blue and buffered Wright-Giemsa stains.
URINALYSIS: Yes
- Time schedule for collection of urine: overnight;
- Metabolism cages used for collection of urine: Yes;
- Animals fasted: Yes;
- Parameters examined: volume, appearance, specific gravity (using a refractometer), and light - microscopic evaluation of sediment were determined. - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes;
HISTOPATHOLOGY: Yes.
Results and discussion
Results of examinations
- Details on results:
- CLINICAL SIGNS AND MORTALITY
One male and one female of the high dose group died on days 2 and 87, respectively. However, this was not statistically significant.
BODY WEIGHT AND WEIGHT GAIN
Mean body weight gain was significantly increased in high dose females and significantly decreased in high-dose males.
HAEMATOLOGY
Significant shift in the leukocyte differential in mid- and low-dose males (increase in segmented neutrophils, decrease in lymphocytes) and lymphocytes were significantly increased in high-dose females. Other hematalogic parameters demonstrating significant changes were increased mean corpuscular hemoglobin in all male rat treatment groups and increased mean corpuscular volume and mean corpuscular hemoglobin concentration in high-dose males.
CLINICAL CHEMISTRY
No substance-related signs of toxicity were observed.
URINALYSIS
Dose-related increase in urine volume, which was significant in high-dose males and high- and mid-dose females, accompanied by a significant decrease in urine specific gravity in high-dose females.
ORGAN WEIGHTS
All significant organ weight changes in male rats occurred at the high dose, including decreased absolute and relative thymus weights and increased relative kidney weights. In high dose female rats, significant changes included increased absolute liver and kidney weights, decreased absolute and relative thymus and uterus weights, and decreased relative brain weight. Absolute liver weights were also significantly increased in mid-dose females.
GROSS PATHOLOGY
No treatment-related gross observations were noted at necropsy .
HISTOPATHOLOGY: NON-NEOPLASTIC
A dose-dependent increase in incidences of mesenteric and/or pancreatic periarteritis was observed in all treated males (control: 1/10; 37.5 mg/kg 1/10; 75 mg/kg: 2/10; 150 mg/kg: 5/10) and females (0/10; 2/10; 2/10; 3/10, respectively). The periarteritis observed in one control male was more consistent with that commonly observed in aged rats and consisted of minimal, focal lymphocytes accumulation adjacent to the artery. Periateritis was characterized by infiltration of mononuclear and polymorphonuclear leukocytes into the media and adventitia, and the more severe lesions included degeneration of medial smooth muscle and periarterial fibrosis. Theophylline-related arterial lesions were noted in the 2 year study only in male rats given the high dose of 75 mg/kg b.w., this effect was statistically significant (see Nyska et al., 1998, Chapter 7.7).
OTHER FINDINGS
There were no significant differences between control and exposed rats in sperm morphology or vaginal cytology parameters. No histological changes were seen in the sex organs.
Effect levels
- Dose descriptor:
- LOAEL
- Effect level:
- 37.5 mg/kg bw/day (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: Periarteritis in both sexes.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.